Cargando…
Intralesional nerve-sparing surgery versus non-surgical treatment for giant cell tumor of the sacrum
BACKGROUND: There is no standard treatment for giant cell tumors of the sacrum. We compared the outcomes and complications in patients with sacral giant cell tumors who underwent intralesional nerve-sparing surgery with or without (neo-) adjuvant therapies versus those who underwent non-surgical tre...
Autores principales: | Tsukamoto, Shinji, Ali, Nikolin, Mavrogenis, Andreas F., Honoki, Kanya, Tanaka, Yasuhito, Spinnato, Paolo, Donati, Davide Maria, Errani, Costantino |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8650241/ https://www.ncbi.nlm.nih.gov/pubmed/34872538 http://dx.doi.org/10.1186/s12891-021-04907-0 |
Ejemplares similares
-
Risk factors of fracture following curettage for bone giant cell tumors of the extremities
por: Tsukamoto, Shinji, et al.
Publicado: (2022) -
Late Local Recurrence of Bone Giant Cell Tumors Associated with an Increased Risk for Malignant Transformation
por: Tsukamoto, Shinji, et al.
Publicado: (2021) -
Association between Inflammatory Markers and Local Recurrence in Patients with Giant Cell Tumor of Bone: A Preliminary Result
por: Tsukamoto, Shinji, et al.
Publicado: (2023) -
Outcome of Reoperation for Local Recurrence Following En Bloc Resection for Bone Giant Cell Tumor of the Extremity
por: Tsukamoto, Shinji, et al.
Publicado: (2022) -
Effect of Adjuvant Chemotherapy on Localized Malignant Giant Cell Tumor of Bone: A Systematic Review
por: Morii, Rokuro, et al.
Publicado: (2021)